(Press-News.org) Toronto, ON (September 15, 2025) – A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance a promising therapy for multiple sclerosis (MS). Supported by Brain Canada, the National MS Society’s Fast Forward program, and Health Canada through the Canada Brain Research Fund, the project is developing a novel approach to treatment that may halt disease progression and repair nerve damage and restore function.
Around 2.8 million people worldwide live with MS, a condition in which the immune system attacks the protective sheath (myelin) around nerve fibers, disrupting communication between the brain and body. Symptoms such as fatigue, vision problems, and mobility challenges arise when myelin is lost. While current treatments can slow disease activity, none can fix existing damage.
This novel therapy offers a different promise. It targets a destructive process known as excitotoxicity, which harms nerve cells in MS. By blocking this process, without interfering with normal brain function, the treatment encourages the body to rebuild myelin and improve nerve recovery. In animal models of MS, the compound has already shown it can restore motor skills and repair myelin, even when applied after symptoms appeared.
The research team, led by principal investigator Dr. Fang Liu, Senior Scientist at CAMH and professor in department of Psychiatry, U of T, in collaboration Dr. Iain Greig, Reader in Medicinal Chemistry at the University of Aberdeen, is now entering the final stages of preclinical testing to prepare for future human clinical trials. If successful, this would mark Canada’s first regenerative treatment for MS, and potentially other neurodegenerative diseases, offering new hope for patients. CAMH and the University of Aberdeen have patent protected this research and are actively seeking industry partners and investors to further advance this work towards clinical trials.
"Canada has one of the highest rates of MS in the world, with an estimated 90,000 people living with the disease. Our compound could transform MS treatment, not just slowing the disease, but helping people regain what they’ve lost. I’m grateful for this new funding to take us one step closer to clinical trials for this potentially life-altering treatment."
- Dr. Fang Liu, Senior Scientist, CAMH
“The potential of this therapy is enormous, not only could it stop MS progression, but it could actually help repair damaged nerves and restore some functions already lost for people living with MS. Being able to take this work forward offers us a unique way to address the root causes of the nerve damage we see in MS patients, and I’m excited by what this could mean for MS patients and others with neurodegenerative diseases. I’m thankful to CAMH, our partners, and the funding agencies for making this possible, and for their belief in the power of this research.”
- Dr. Iain Greig, Reader in Medicinal Chemistry, University of Aberdeen
“CAMH is proud to be leading this groundbreaking work alongside our partners and contributors. As a global leader in mental health and neuroscience research, we are deeply committed to advancing care through innovation. By supporting the commercialization of discoveries like this, we can accelerate the translation of research into real-world treatments and deliver new hope to people living with multiple sclerosis and other neurodegenerative diseases.”
— Dr. Aristotle Voineskos, CAMH Senior Vice President, Research and Science
— Dr. Viviane Poupon, Brain Canada President & CEO
“We are pleased to see research advance on a pathway toward stopping MS progression in its tracks and restoring function to people with progressive MS.”
— Dr. Walter Kostich, Associate Vice President, Translational Research, National MS Society
This project has been made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) and Brain Canada, and Fast Forward. Past funding has also been provided by a CAMH Discovery Fund Accelerator grant, a CIHR POP II grant, an operating grant from the MS Society of Canada and funding from the National MS Society’s (USA) Fast Forward commercial research program.
– 30 –
About the Centre for Addiction and Mental Health (CAMH)
The Centre for Addiction and Mental Health (CAMH) is Canada's largest mental health and addiction teaching hospital and a world leading research centre in this field. CAMH combines clinical care, research, education, policy development and health promotion to help transform the lives of people affected by mental illness and addiction. CAMH is fully affiliated with the University of Toronto and is a Pan American Health Organization/World Health Organization Collaborating Centre. For more information, please visit camh.ca or follow @CAMHnews on Bluesky and LinkedIn.
About Brain Canada
Brain Canada is a national charitable organization that enables and supports excellent, innovative, and collaborative brain research in Canada. Through the Canada Brain Research Fund, a public-private partnership with the Government of Canada through Health Canada, Brain Canada funds initiatives that advance knowledge, drive innovation, and accelerate the development of diagnostics, treatments, and cures.
About the National Multiple Sclerosis Society
The National MS Society, founded in 1946, is the global leader of a growing movement dedicated to creating a world free of MS. The Society funds cutting-edge research for a cure, drives change through advocacy and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalmssociety.org, Facebook, X (formerly known as Twitter), Instagram, YouTube or 1-800-344-4867.
END
New funding fuels development of first potentially regenerative treatment for multiple sclerosis
A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance a promising therapy for multiple sclerosis (MS)
2025-09-15
ELSE PRESS RELEASES FROM THIS DATE:
NJIT student–faculty team wins best presentation award for ant swarm simulation
2025-09-15
Think twice about eliminating those pesky ants at your next family picnic. Their behavior may hold the key to reinventing how engineering materials, traffic control and multi-agent robots are made and utilized, thanks to research conducted by recent graduate Matthew Loges ’25 and Assistant Professor Tomer Weiss from NJIT's Ying Wu College of Computing.
The two earned a best presentation award for their research paper titled “Simulating Ant Swarm Aggregations Dynamics” at the ACM SIGGRAPH Symposium for Computer Animation (SCA), and a qualifying poster nomination for the undergraduate research competition at the 2025 ACM SIGGRAPH conference.
SIGGRAPH, ...
Ants defend plants from herbivores but can hinder pollination
2025-09-15
Around 4,000 plant species from different parts of the world secrete nectar outside their flowers, such as on their stems or leaves, through secretory glands known as extrafloral nectaries. Unlike floral nectar, extrafloral nectar does not attract pollinators; rather, it attracts insects that defend plants, such as ants. These insects feed on the sweet liquid and, in return, protect the plant from herbivores. However, this protection comes at a cost.
A study published in the Journal of ...
When the wireless data runs dry
2025-09-15
To train artificial intelligence (AI) models, researchers need good data and lots of it. However, most real-world data has already been used, leading scientists to generate synthetic data. While the generated data helps solve the issue of quantity, it may not always have good quality, and assessing its quality has been overlooked.
Wei Gao, associate professor of electrical and computer engineering at the University of Pittsburgh Swanson School of Engineering, has collaborated with researchers ...
Inquiry into the history of science shows an early “inherence” bias
2025-09-15
Early scientific theories—such as those explaining basic phenomena like gravity, burning, and the movement of molecules in water—centered on presumed inherent properties rather than external factors, thereby misleading famous philosophers and scientists, from Aristotle to Scottish botanist Robert Brown, in their theorizing.
A new study by a team of psychology researchers has now found that this tendency is in fact common in the history of science. Moreover, through a series of experiments and surveys, the paper’s authors conclude these misfires were likely driven by cognitive constraints, among scientists and non-scientists alike, that have acted ...
Picky eaters endure: Ecologists use DNA to explore diet breadth of wild herbivores
2025-09-15
LOGAN, UTAH, USA – It’s not easy eating green. Most plants are heavily defended with chemicals to deter plant eaters. For these herbivores, getting enough to eat, while minimizing exposure to toxins, is a persistent challenge that shapes their foraging choices.
Understanding how these animals navigate these choices is fundamental to understanding what these creatures need to survive and how species respond to changing conditions, says Utah State University ecologist Sara Weinstein.
Woodrats (genus Neotoma) provide an unexpected model for studying animal diets, she says. Native to North America, these herbivorous rodents ...
Study suggests most Americans would be healthier without daylight saving time
2025-09-15
Every spring, Americans dutifully adjust their clocks forward to daylight saving time, and every fall, back to standard time — but no one seems very happy about it. The biannual time shift is not only inconvenient, it’s also known to be acutely bad for our health. The collective loss of an hour of sleep on the second Sunday in March has been linked to more heart attacks and fatal traffic accidents in the ensuing days.
Now, a study by Stanford Medicine researchers finds there are longer-term hazards as well — and better alternatives.
The researchers compared how three ...
Increasing the level of the protein PI31 demonstrates neuroprotective effects in mice
2025-09-15
One fundamental feature of neurodegenerative diseases is a breakdown in communication. Even before brain cells die, the delicate machinery that keeps neurons in touch—by clearing away protein waste at the synapses—starts to fail. When the cleanup falters, the connections between brain cells is impaired and the flow of signals responsible for reasoning, language, memory, and even basic bodily functions is progressively disrupted.
Now, a new study identifies a novel strategy for preventing unwanted proteins from clogging synapses and ultimately congealing into protein plaques. The ...
Multi-energy X-ray curved surface imaging-with multi-layer in-situ grown scintillators
2025-09-15
As a promising technology, multi-energy X-ray imaging technology is expected to be applied for many key fields such as distinguishing the subtle differences in material composition and density, like showing biological skeleton and muscle defects. However, the current multi-energy X-ray imaging technology usually has a high threshold in material selection and device design. To ensure that the imaging resolution reaches the expected level, it is necessary to efficiently couple the multi-layer scintillators with specific energy X-ray response characteristics. ...
Metasurface enables compact and high-sensitivity atomic magnetometer
2025-09-15
The powerful light field manipulation capability of metasurfaces offers a novel development perspective for the quantum precision measurement. By applying the phase-gradient metasurface (PGM) to atomic magnetometers (AMs), we have proposed and experimentally demonstrated a new type of compact single-beam elliptically polarized atomic magnetometers (EPAMs). Employing the fabricated chiral beam splitter PGM with high cross-polarization transmittance, a new atomic spin chirality detection method was devised, enabling the ultra-high sensitivity for extremely weak magnetic ...
PFAS presence confirmed in the blood of children in Gipuzkoa
2025-09-15
These chemical compounds are highly stable and linger in the environment. Thanks to their water-, oil- and stain-repellent properties, they are widely found in everyday items, such as non-stick pans, waterproof clothing, food containers and fire-fighting foams. Their widespread use has harmful effects; they can enter the human body during pregnancy via the placenta and continue to build up through breastfeeding, food, drinking water, polluted air, or contact with products containing them.
Due to their impact on health, these chemical ...
LAST 30 PRESS RELEASES:
Interactive apps, AI chatbots promote playfulness, reduce privacy concerns
How NIL boosts college football’s competitive balance
Moffitt researchers develop machine learning model to predict urgent care visits for lung cancer patients
Construction secrets of honeybees: Study reveals how bees build hives in tricky spots
Wheat disease losses total $2.9 billion across the United States and Canada between 2018 and 2021
New funding fuels development of first potentially regenerative treatment for multiple sclerosis
NJIT student–faculty team wins best presentation award for ant swarm simulation
Ants defend plants from herbivores but can hinder pollination
When the wireless data runs dry
Inquiry into the history of science shows an early “inherence” bias
Picky eaters endure: Ecologists use DNA to explore diet breadth of wild herbivores
Study suggests most Americans would be healthier without daylight saving time
Increasing the level of the protein PI31 demonstrates neuroprotective effects in mice
Multi-energy X-ray curved surface imaging-with multi-layer in-situ grown scintillators
Metasurface enables compact and high-sensitivity atomic magnetometer
PFAS presence confirmed in the blood of children in Gipuzkoa
Why do people believe lies?
SwRI installs private 5G network for research, development, testing and evaluation
A new perspective in bone metabolism: Targeting the lysosome–iron–mitochondria axis for osteoclast regulation
Few military spouses use formal support services during, after deployment
Breakthrough in the hunt for light dark matter: QROCODILE project reveals world-leading constraints
2D x-ray imaging technique reveals hidden processes in CO2 electrolyzers
Rational high entropy doping strategy via modular in-situ/post solvothermal doping integration for microwave absorption
Circular Economy has been officially included in the ESCI
Recent advances in exciton-polariton in perovskite
Efficacy and safety of GLP-1 RAs in children and adolescents with obesity or type 2 diabetes
Over-the-counter sales of overdose reversal drug naloxone decline after initial surge
Global trends and disparities in social isolation
Country of birth, race, ethnicity, and prenatal depression
Kissick Family Foundation, Milken Institute announce $2 million in funding for frontotemporal dementia research and new call for proposals
[Press-News.org] New funding fuels development of first potentially regenerative treatment for multiple sclerosisA Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance a promising therapy for multiple sclerosis (MS)